BioAge Labs Rings the Nasdaq Stock Market Opening Bell
BioAge Labs (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Kristen Fortney, CEO and Co-Founder of BioAge Labs, rings the Opening Bell.